Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Electronic Trial Master File (eTMF) Market
Electronic Trial Master File (eTMF) Market size was valued at USD 1.2 billion in 2023 and is expected to grow at a CAGR of 9.5% between 2024 and 2032. The market growth is propelled by factors such as the growing adoption of ETMF systems, and technological advancements in electronic trial master file systems. Additionally, increasing government funding for clinical trials is one of the key contributing factors to the market growth.
For instance, as of 2022, the National Institute of Health (NIH) has funded approximately USD 45 billion to improve human life and reduce illness and disability. Similarly, NIH has also granted exploratory clinical trials grant that aimed to foster clinical trials that will lead to clinically meaningful improvements in diagnosis, prevention, and treatment of disease conditions. Such funding fosters the development and implementation of various exploratory clinical trials, thereby boosting the market growth.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Electronic Trial Master File Market Size in 2023: | USD 1.2 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 9.5% |
2024 – 2032 Value Projection: | USD 2.8 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 165 |
Tables, Charts & Figures: | 246 |
Segments covered: | Component, Delivery Mode, Clinical Trial Phase, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
An electronic trial master file (eTMF) is a digital repository or system designed to securely store, organize, and manage the extensive documentation generated during the conduct of a clinical trial. It serves as a centralized platform for housing essential trial-related documents, such as study protocols, investigator brochures, case report forms, informed consent forms, regulatory submissions, correspondence, and other pertinent materials.